These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 31682183)

  • 1. Correction to:
    J Ocul Pharmacol Ther; 2019 Nov; 35(9):522. PubMed ID: 31682183
    [No Abstract]   [Full Text] [Related]  

  • 2. Correction to: Efficacy and Safety of 0.6% Pazufloxacin Ophthalmic Solution Versus Moxifloxacin 0.5% and Gatifloxacin 0.3% in Subjects with Bacterial Conjunctivitis: A Randomized Clinical Trial, by Baiza-Durán, L., Olvera-Montaño, O., Mercado-Sesma, A.R., and Oregon-Miranda, A.A. J Ocul Pharmacol Ther 2018;34(3):250-255. DOI: 10.1089/jop.2017.0056.
    J Ocul Pharmacol Ther; 2019; 35(1):76. PubMed ID: 30699060
    [No Abstract]   [Full Text] [Related]  

  • 3. Correction to:
    J Ocul Pharmacol Ther; 2020; 36(1):70-71. PubMed ID: 31971894
    [No Abstract]   [Full Text] [Related]  

  • 4. Correction to: Matrix Metalloproteinases and Glaucoma Treatment, by Weinreb, R.N., Robinson, M.R., Dibas, M. and Stamer, W.D. J Ocul Pharmacol Ther 2020;36(4):208-228. DOI: 10.1089/jop.2019.0146.
    J Ocul Pharmacol Ther; 2020; 36(6):484. PubMed ID: 32721205
    [No Abstract]   [Full Text] [Related]  

  • 5. Correction to:
    J Ocul Pharmacol Ther; 2019 Dec; 35(10):578. PubMed ID: 31794284
    [No Abstract]   [Full Text] [Related]  

  • 6. Correction to: J Ocul Pharmacol Ther 2015;31(7);413-418; DOI: 10.1089/jop.2015.0017.
    J Ocul Pharmacol Ther; 2015 Nov; 31(9):585. PubMed ID: 26535553
    [No Abstract]   [Full Text] [Related]  

  • 7. Correction to: The Effect of Posture on Intraocular Pressure and Systemic Hemodynamic Parameters in Treated and Untreated Patients with Primary Open-Angle Glaucoma, by Katsanos, A., Dastiridou, A.I., Quaranta, L., Rulli, E., Riva, I., Dimasi, V., Tsironi, E.E., and Weinreb, R.N. J Ocul Pharmacol Ther 2017;33(8):598-603. DOI: 10.1089/jop.2017.0030.
    J Ocul Pharmacol Ther; 2018 Apr; 34(3):309. PubMed ID: 29393727
    [No Abstract]   [Full Text] [Related]  

  • 8. Correction to:
    J Ocul Pharmacol Ther; 2020 Mar; 36(2):133. PubMed ID: 32150501
    [No Abstract]   [Full Text] [Related]  

  • 9.
    J Ocul Pharmacol Ther; 2023 Jun; 39(5):359. PubMed ID: 37310367
    [No Abstract]   [Full Text] [Related]  

  • 10. Comments on 'Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond' by M. J. Pencina, R. B. D'Agostino Sr, R. B. D'Agostino Jr, R. S. Vasan, Statistics in Medicine (DOI: 10.1002/sim.2929).
    Greenland P
    Stat Med; 2008 Jan; 27(2):188-90. PubMed ID: 17579927
    [No Abstract]   [Full Text] [Related]  

  • 11. Comments on 'Evaluating the added predictive ability of a new marker' by M. Pencina, R. D'Agostino, R. D'Agostino Jr, R. Vasan, Statistics in Medicine (DOI: 10.1002/sim.2929).
    Kraemer HC
    Stat Med; 2008 Jan; 27(2):196-8. PubMed ID: 18041049
    [No Abstract]   [Full Text] [Related]  

  • 12. Correction to:
    J Adolesc Young Adult Oncol; 2020 Apr; 9(2):313-314. PubMed ID: 32315278
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter to the editor regarding Gerente, V.M., Biondi, A.C., Barbosa, C.P., et al. Effect of brimonidine tartrate 0.15% on scotopic pupil: controlled trial. J. Ocul. Pharmacol. Ther 23:476-480, 2007.
    Khanani AM; Brown SM
    J Ocul Pharmacol Ther; 2008 Jun; 24(3):364-5; author reply 366. PubMed ID: 18476806
    [No Abstract]   [Full Text] [Related]  

  • 14. Ocular gelfoam disc-applicator for pupillary dilation in humans. Negvesky GJ, butrus SI, abifarah HA, lee YC, yalkowsky SH(1). J ocul pharmacol ther 2000;16:311-315.
    Am J Ophthalmol; 2000 Dec; 130(6):864. PubMed ID: 11124328
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: "Pharmacokinetic Analysis of Intraocular Penetration of Latanoprost Solutions with Different Preservatives in Human Eyes" by Sekine et al. (J. Ocul. Pharmacol. Ther. 2018;34:280-286).
    Novack GD
    J Ocul Pharmacol Ther; 2018; 34(6):429-430. PubMed ID: 29924675
    [No Abstract]   [Full Text] [Related]  

  • 16. Erratum for the Research Article: "Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory" by G. Oliveira, E. Ruggiero, M. T. L. Stanghellini, N. Cieri, M. D'Agostino, R. Fronza, C. Lulay, F. Dionisio, S. Mastaglio, R. Greco, J. Peccatori, A. Aiuti, A. Ambrosi, L. Biasco, A. Bondanza, A. Lambiase, C. Traversari, L. Vago, C. von Kalle, M. Schmidt, C. Bordignon, F. Ciceri, C. Bonini.
    Sci Transl Med; 2015 Dec; 7(319):319er9. PubMed ID: 26702089
    [No Abstract]   [Full Text] [Related]  

  • 17. Response #1 to Immediate Intraocular Pressure Tendency Following Intravitreal Delivery of Dexamethasone Implant; Alagöz et al. J. Ocul. Pharmacol. Ther. 32:44-49, 2016.
    Çekiç O; Turhan SA
    J Ocul Pharmacol Ther; 2016; 32(6):343. PubMed ID: 27058573
    [No Abstract]   [Full Text] [Related]  

  • 18. Response #2 to Immediate Intraocular Pressure Tendency Following Intravitreal Delivery of Dexamethasone Implant; Alagöz et al. J. Ocul. Pharmacol. Ther. 32:44-49, 2016.
    Garay-Aramburu G; Gomez-Moreno A
    J Ocul Pharmacol Ther; 2016; 32(6):344-5. PubMed ID: 27420301
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: "Safety Profile of Stromal Hydration of Clear Corneal Incisions with Cefuroxime in the Mouse Model" by Moosajee et al. (J. Ocul. Pharmacol. Ther. 32:469-475, 2016).
    Aslankurt M; Andı İ; Çekiç O
    J Ocul Pharmacol Ther; 2017 Jun; 33(5):337. PubMed ID: 28263663
    [No Abstract]   [Full Text] [Related]  

  • 20. Comments on 'Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers' by M. J. Pencina, R. B. D'Agostino, Sr. and E. W. Steyerberg.
    Cook NR; Paynter NP
    Stat Med; 2012 Jan; 31(1):93-5; author reply 96-7. PubMed ID: 21344474
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.